Category | Non-stimulant | Stimulants | |||||
---|---|---|---|---|---|---|---|
Brand Name | Strattera® | Ritalin® | Concerta® (18-36/27 mg) | Equasym XL® | Medikinet® | Medikinet XL® (5/10-40 mg) | Not applicable |
Generic Name | Atomoxetine | MPH | MPH | MPH | MPH | MPH | Dexamfetamine |
General | Â | Â | Â | Â | Â | Â | Â |
Hypersensitivity | X | X | X | X | X | X | X |
(Narrow angle) Glaucoma | (X) | X | X | X | X | X | X |
With MAIOs/Within 14 days | X | X | X | X | X | X | X |
Pregnancy/lactation | Â | Â | Â | Â | Â | Â | X |
Pronounced anacidity of the stomach | Â | Â | Â | Â | Â | X | Â |
With H2-receptor blockers/antacid therapy | Â | Â | Â | Â | Â | X | Â |
Sucrose/lactose intolerances and related disorders | Â | Â | Â | Â | Â | Â | X |
Porphyria | Â | Â | Â | Â | Â | Â | X |
Pheochromocytoma | X | X | X | X | X | X | Â |
Psychiatric | Â | Â | Â | Â | Â | Â | Â |
Hyperexcitability | Â | Â | Â | Â | Â | Â | X |
Severe depression | Â | X | X | X | X | X | Â |
Anorexia nervosa | Â | X | X | X | X | X | Â |
Psychopatho-logical personality structure | Â | X | X | X | X | X | Â |
Suicidal tendency | Â | X | X | X | X | X | Â |
Psychotic symptoms | Â | X | X | X | X | X | Â |
Schizophrenia | Â | X | X | X | X | X | Â |
Mania/bipolar disorder | Â | X | X | X | X | X | Â |
Severe mood disorders | Â | X | X | X | X | X | Â |
Drug or alcohol abuse | Â | Â | Â | Â | Â | Â | X |
Endocrinological | Â | Â | Â | Â | Â | Â | Â |
Hyperthyroidism/thyrotoxicosis | Â | X | X | X | X | X | X |
Cardiac | Â | Â | Â | Â | Â | Â | Â |
Patients with severe cardiovascular § or cerebrovascular †disorders whose condition would be expected to deteriorate if they experienced increases in blood pressure or heart rate that could be clinically important | X |  |  |  |  |  |  |
Pre existing cardiovascular disorders:§* |  |  |  |  |  |  |  |
   Angina |  | X | X | X | X | X |  |
   Life threatening arrhythmias and channelopathies |  | X | X | X | X | X |  |
   (Moderate or) Severe hypertension |  | X | X | X | X | X | (X) |
   Heart failure |  | X | X | X | X | X |  |
   Myocardial infarction |  | X | X | X | X | X |  |
   Arterial occlusive disease |  | X | X | X | X | X |  |
   Haemodynamically significant congenital heart disease |  | X | X | X | X | X |  |
   Cardiomyopathies |  | X | X | X | X | X |  |
Known risk factors for cerebrovascular disorder | Â | X | Â | Â | Â | Â | Â |
Structural cardiac abnormality | Â | Â | Â | Â | Â | Â | X |
Symptomatic cardiovascular disease | Â | Â | Â | Â | Â | Â | X |
Advanced arteriosclerosis | Â | Â | Â | Â | Â | Â | X |
Pre-existing (severe) cerebrovascular disorders | (X)†| X | X | X | X | X |  |
Neurological | Â | Â | Â | Â | Â | Â | Â |
Tourette's syndrome/similar dystonias | Â | Â | Â | Â | Â | Â | X |